Review
Open access
Sep 2026
Botulinum Toxin for Temporomandibular Disorder: Current Evidence, Clinical Applications, and Future Perspectives
Temporomandibular disorders (TMDs) are heterogeneous musculoskeletal conditions frequently characterized by pain, impaired mandibular function, and reduced quality of life. Botulinum neurotoxin type A (BoNT-A) has emerged as a potential therapeutic option, particularly for persistent myogenous TMDs associated with mast...
Martina Ferrillo, C. Curci, Dario Calafiore et al.
· Toxins · 0 citations